Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
Developmental origins and emerging therapeutic opportunities for childhood cancer
Mariella Filbin1, Michelle Monje2
1Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA, USA.
Abstract:
Cancer is the leading disease-related cause of death in children in developed countries. Arising in the context of actively growing tissues, childhood cancers are fundamentally diseases of dysregulated development. Childhood cancers exhibit a lower overall mutational burden than adult cancers, and recent sequencing studies have revealed that the genomic events central to childhood oncogenesis include mutations resulting in broad epigenetic changes or translocations that result in fusion oncoproteins. Here, we will review the developmental origins of childhood cancers, epigenetic dysregulation in tissue stem/precursor cells in numerous examples of childhood cancer oncogenesis and emerging therapeutic opportunities aimed at both cell-intrinsic and microenvironmental targets together with new insights into the mechanisms underlying long-term sequelae of childhood cancer therapy.
Insights
Childhood cancers stem from developmental errors, often involving epigenetic changes or fusion oncoproteins rather than high mutation rates. Understanding these origins informs new therapies targeting cancer cells and their environment, and addresses long-term treatment effects.
Area of Science:
- Pediatric oncology
- Developmental biology
- Cancer genomics
Background:
- Childhood cancers are the primary disease-related cause of death in developed nations.
- These cancers originate from actively growing tissues, indicating they are fundamentally diseases of dysregulated development.
- Compared to adult cancers, childhood cancers have a lower mutational burden.
Purpose of the Study:
- To review the developmental origins of childhood cancers.
- To examine epigenetic dysregulation in tissue stem/precursor cells during childhood cancer development.
- To discuss emerging therapeutic strategies and long-term sequelae of childhood cancer therapy.
Main Methods:
- Review of recent sequencing studies on childhood cancers.
- Analysis of genomic events, including epigenetic changes and translocations.
- Synthesis of information on therapeutic targets and treatment side effects.
Main Results:
- Childhood oncogenesis frequently involves epigenetic alterations or translocations forming fusion oncoproteins.
- Dysregulated development in tissue stem/precursor cells is a key mechanism.
- Emerging therapies target both intrinsic cell processes and the tumor microenvironment.
Conclusions:
- Childhood cancers arise from specific developmental disruptions.
- Targeting epigenetic dysregulation and fusion oncoproteins offers therapeutic potential.
- Addressing long-term effects of therapy is crucial for survivors.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Emerging Adulthood
Introduction to Developmental Psychology
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Introduction Cardiac Emergencies

